Biotech Stocks to Watch: Axsome and Innoviva Lead the Way

Axsome Therapeutics and Innoviva are biotech companies with potentially transformational products in development. Axsome's oral therapy AXS-05 is being reviewed by the FDA for the treatment of agitation associated with Alzheimer's, while Innoviva's Nuzolvence, a single-dose oral antibiotic, has been approved to treat gonorrhea. Both companies have strong pipelines and could draw investor attention in 2026.